MPM Capital is a Boston, Massachusetts–based life sciences venture capital firm founded in 1996 that invests in early through growth stage biopharmaceutical, medical technology, and healthcare innovation companies. The firm partners with entrepreneurs and scientific founders to advance novel therapeutics, medical devices, diagnostics, and platform technologies from early development toward clinical proof-of-concept and commercial expansion. MPM Capital manages multiple investment funds and deploys capital globally, with a portfolio spanning biotech and healthcare innovation sectors. Its investment approach combines scientific and clinical expertise with strategic support to navigate complex regulatory and market pathways. The firm typically participates in significant financings from Series A through later stages and collaborates with industry stakeholders to accelerate portfolio company progress. MPM Capital has been involved in numerous company formations and financings that have contributed to advancements in health care and life sciences.